A new third-order family of nonlinear solvers for multiple roots

AbstractIn this paper, a new family of third-order methods for finding multiple roots of nonlinear equations has been introduced. This family requires one-function and two-derivative evaluation per iteration. The family contains several known third-order methods, as special cases. Some examples are presented to show the performance of the presented family

An Analytical Study for (2 + 1)-Dimensional Schrödinger Equation

In this paper, the homotopy analysis method has been applied to solve (2 + 1)-dimensional Schrödinger equations. The validity of this method has successfully been accomplished by applying it to find the solution of some of its variety forms. The results obtained by homotopy analysis method have been compared with those of exact solutions. The main objective is to propose alternative methods of finding a solution, which do not require small parameters and avoid linearization and physically unrealistic assumptions. The results show that the solution of homotopy analysis method is in a good agreement with the exact solution

The Convergence Study of the Homotopy Analysis Method for Solving Nonlinear Volterra-Fredholm Integrodifferential Equations

We aim to study the convergence of the homotopy analysis method (HAM in short) for solving special nonlinear Volterra-Fredholm integrodifferential equations. The sufficient condition for the convergence of the method is briefly addressed. Some illustrative examples are also presented to demonstrate the validity and applicability of the technique. Comparison of the obtained results HAM with exact solution shows that the method is reliable and capable of providing analytic treatment for solving such equations

Some Higher-Order Families of Methods for Finding Simple Roots of Nonlinear Equations

Abstract In this paper, a new fifth-order family of methods fre

Numerical solution of functional integral equations by the variational iteration method

AbstractIn the present article, we apply the variational iteration method to obtain the numerical solution of the functional integral equations. This method does not need to be dependent on linearization, weak nonlinearity assumptions or perturbation theory. Application of this method in finding the approximate solution of some examples confirms its validity. The results seem to show that the method is very effective and convenient for solving such equations

Application of the Variational Iteration Method for Solving Differential -Difference Equations

Abstract In this paper, an application of variational iteration method is applied to solve differential -difference equations (DDE

Fractional dynamics and computational analysis of food chain model with disease in intermediate predator

In this paper, a fractional food chain system consisting of a Holling type Ⅱ functional response was studied in view of a fractional derivative operator. The considered fractional derivative operator provided nonsingular as well as a nonlocal kernel which was significantly better than other derivative operators. Fractional order modeling of a model was also useful to model the behavior of real systems and in the investigation of dynamical systems. This model depicted the relationship among four types of species: prey, susceptible intermediate predators (IP), infected intermediate predators, and apex predators. One of the significant aspects of this model was the inclusion of Michaelis-Menten type or Holling type Ⅱ functional response to represent the predator-prey link. A functional response depicted the rate at which the normal predator consumed the prey. The qualitative property and assumptions of the model were discussed in detail. The present work discussed the dynamics and analytical behavior of the food chain model in the context of fractional modeling. This study also examined the existence and uniqueness related analysis of solutions to the food chain system. In addition, the Ulam-Hyers stability approach was also discussed for the model. Moreover, the present work examined the numerical approach for the solution and simulation for the model with the help of graphical presentations

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND: Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021. METHODS: We estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined. FINDINGS: Globally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer. INTERPRETATION: As the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed